Posters presented in 2014


ASH POM-DEX

A Phase 1/2 Study (NCT01541332) of Pomalidomide (POM), Dexamethasone (DEX) and Pegylated Liposomal Doxorubicin (PLD) for Patients with Relapsed/Refractory (R/R) Multiple Myeloma (MM)

POM-DEX ASH

Download Results of this Study


ASH PN after Bortezomib retreatment

A retrospective study to evaluate the incidence and severity of peripheral neuropathy for Relapsed/Refractory (R/R) Multiple Myeloma (MM) patients upon retreatment with Bortezomib

PN Retro ASH

Download Results of this Study